HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC Targets Unmasking 'Native Advertising' In Policy Update

This article was originally published in The Tan Sheet

Executive Summary

FTC publishes enforcement policy statement addressing increases in native advertising and deceptively formatted ads. The statement explains how the commission will apply its current enforcement standards to target deceptive content, including promotions disguised as news stories, in violation of its policies.

You may also be interested in...



Vitafusion Absorption Claim Review May Touch Supplement Industry Nerve About Disclosures

Council of Better Business Bureaus division, reviewing Pharmavite challenge, found Church & Dwight doesn't support or sufficiently qualify “clinically proven absorption” claims for vitafusion vitamin C and D3 products in a decision that swung on a corollary to an oft-cited standard for consumer health product advertising, that results of tests on separate ingredients are not relevant to claims for products.

FDA And FTC Rules Apply To Native Advertising, Attorneys Caution

Native advertising, or advertising designed to blend in with nearby non-advertising content, is becoming more popular with the growth of digital marketing. But companies need to be cautious about using the medium in compliance with federal rules.

FDA And FTC Rules Indigenous To Native Advertising, Attorneys Caution

Native advertising, advertising designed to blend in with nearby non-advertising content, is becoming more popular with the growth of digital marketing. But device-makers need to be cautious about using the medium in compliance with federal promotional rules.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108744

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel